The most dominant reason for poor ovarian response is the decline of ovarian reserve.
目前认为卵巢反应不良或卵巢低反应的主要原因是卵巢储备功能的下降。
The lower activity of telomerase in granulosa cells may related to the mechanism of poor ovarian response.
卵巢反应不良患者黄素化颗粒细胞中端粒酶活性低，可能参与卵巢反应不良的发生。
Results:The proportion of poor ovarian response and the number of cancelled cycles were increased with the gain of women's age.
结果：随年龄增加，卵巢反应不良及取消周期的比例增加；
The various superovulatory treatment regimes showed no significant effects on the secretion of FSH or on ovarian response and embryo yield.
不同的超排处理对FSH的分泌、卵巢反应和胚胎产量没有影响。
Objective: to investigate the clinical effect of Ginkgo leaf preparation (GLP) on patients with poor ovarian response to assisted reproductive technology.
目的：探讨银杏叶制剂对助孕技术治疗中卵巢反应低下患者的临床疗效。
It is also unique in that it placed an emphasis on the impact of a patient's age, her ovarian response, the characteristics of her cycle, and the final outcome - a birth.
此研究的独特处也在于它强调了病人年龄、卵巢反应、周期特点、以及最终结局—胎儿出生的影响。
Salpingectomy has no obvious effect on the outcome of IVF-ET and baseline endocrine within a period of time, but it reduces the ovarian response to superovulation on ipsilateral ovary in IVF-ET.
输卵管切除术对IVF - ET周期妊娠结局无显著影响，在一定时间内不引起患者基础内分泌的改变，但降低手术侧卵巢的反应性。
To study the response rate and toxic side effects of vindesine, aclarubicin and mitomycin(VAM) as a new regimen of second line chemotherapy for ovarian carcinoma.
目的研究长春酰胺、阿克拉霉素、丝裂霉素联合化疗治疗耐药卵巢癌的疗效和毒性反应。
In order to reduce the human anti mouse antibody response and obtain optimal antigenicity, anti idiotype single chain which mimicking ovarian cancer antigen has been humanized.
为了降低人抗鼠抗体反应，获得满意的免疫原性，将模拟人卵巢癌抗原的抗独特型单链抗体人源化。
History of poor response to ovarian stimulation was a strong indicator for declining ovarian function.
促排卵反应不良病史也是卵巢低反应性的影响因素。
Researchers dedicated to finding indicators, such as CA125, D-dimer, which can be used in early diagnosis of ovarian cancer, treatment response monitoring and prognosis.
研究者致力于寻找指标，如CA125、D-二聚体，以应用于卵巢癌的早期诊断、疗效观察及预后评估。
Researchers dedicated to finding indicators, such as CA125, D-dimer, which can be used in early diagnosis of ovarian cancer, treatment response monitoring and prognosis.
研究者致力于寻找指标，如CA125、D-二聚体，以应用于卵巢癌的早期诊断、疗效观察及预后评估。
应用推荐